Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2691550013 | Lanreotide acetate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2692194013 | Lanreotide acetate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2580111000052117 | lanreotidacetat | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lanreotide acetate (substance) | Is a | Lanreotide (substance) | false | Inferred relationship | Some | ||
| Lanreotide acetate (substance) | Has disposition (attribute) | Hypothalamic inhibiting factor (disposition) | true | Inferred relationship | Some | ||
| Lanreotide acetate (substance) | Is a | Somatostatin analog (substance) | true | Inferred relationship | Some | ||
| Lanreotide acetate (substance) | Is modification of (attribute) | Lanreotide (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| lanreotid 120 mg, förfylld spruta 0,5 ml | Has active ingredient | False | Lanreotide acetate (substance) | Inferred relationship | Some | |
| lanreotid 60 mg, förfylld spruta 0,3 ml | Has active ingredient | False | Lanreotide acetate (substance) | Inferred relationship | Some | |
| lanreotid 90 mg, förfylld spruta 0,3 ml | Has active ingredient | False | Lanreotide acetate (substance) | Inferred relationship | Some | |
| lanreotid 30 mg, pulver och vätska för injektionssuspension, flaska | Has active ingredient | False | Lanreotide acetate (substance) | Inferred relationship | Some | |
| Lanreotide (as lanreotide acetate) 30 mg powder for suspension for injection vial | Has precise active ingredient | True | Lanreotide acetate (substance) | Inferred relationship | Some | 1 |
Reference Sets
FHIR